Hyperfine, Inc. has announced the appointment of Thomas Teisseyre, Ph.D., as the Chief Operating Officer, effective July 24, 2023. Meanwhile, Khan Siddiqui, M.D., the Company’s Chief Medical Officer and Chief Strategy Officer, will transition to a 20% part-time employee schedule from July 24, 2023, with a revised annual base salary of $87,360.